Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
    La, Jennifer
    Cheng, David
    Brophy, Mary T.
    Do, Nhan V.
    Lee, Jerry S. H.
    Tuck, David
    Fillmore, Nathanael R.
    JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 918 - 928
  • [33] Real-World Treatment with Checkpoint Inhibitors: The Swedish Experience
    Gagatek, S.
    Backman, M.
    Mattsson, J.
    Lamberg, K.
    Brostrom, E.
    Botling, J.
    Micke, P.
    Isaksson, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S978 - S978
  • [34] A Cautionary Note: "Real-World" Toxicity of Checkpoint Inhibitors
    Markman, Maurie
    ONCOLOGY, 2018, 94 (05) : 257 - 258
  • [35] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
    Kim, Hyera
    Kwon, Minsuk
    Kim, Binnari
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Park, Keunchil
    Ahn, Myung-Ju
    BMC CANCER, 2020, 20 (01)
  • [36] Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma
    Sun, Meiling
    Ji, Huaijun
    Xu, Ning
    Jiang, Peng
    Qu, Tao
    Li, Yu
    BMC CANCER, 2022, 22 (01)
  • [37] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
    Hyera Kim
    Minsuk Kwon
    Binnari Kim
    Hyun Ae Jung
    Jong-Mu Sun
    Se-Hoon Lee
    Keunchil Park
    Myung-Ju Ahn
    BMC Cancer, 20
  • [38] Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma
    Meiling Sun
    Huaijun Ji
    Ning Xu
    Peng Jiang
    Tao Qu
    Yu Li
    BMC Cancer, 22
  • [39] The association between body mass index and immune checkpoint inhibitors outcomes in melanoma: Results from real-world data
    Elantably, Dina
    Wang, Jiasheng
    Al Armashi, Abdul Rahman
    Al Zubaidi, Anas
    Alkrekshi, Akram
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
    Jain, P.
    Bugarin, J. Gutierrez
    Guha, A.
    Jain, C.
    Patil, N.
    Shen, T.
    Stanevich, I.
    Nikore, V.
    Margolin, K.
    Ernstoff, M.
    Velcheti, V.
    Barnholtz-Sloan, J.
    Dowlati, A.
    ESMO OPEN, 2021, 6 (05)
12345